Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
VenatoRx Pharmaceuticals Inc.
3156
VenatoRx Pharmaceuticals Inc.
Technology
Biotechnology
VenatoRx Pharmaceuticals, a disease-focused pharmaceutical company, focuses onthe discovery and development of novel anti-infective agents.
Suggest edits
Type
B2b
Raised
$51.4M
Follow us
Companies in the same industry
PneumaCare
Biolase
Scripps Research
Wakati
Clinipace Worldwide
Merganser Biotech, Inc.
ORRECO
Advanced Cell Dx
Oxford Nanopore
LifeBond
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
$9,400,000
Grant - 2017
CARB-X
$42,000,000
Venture capital (Series B) - 2017
Foresite Capital
Abingworth
Versant Ventures
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
$9,400,000
Grant
businesswire
VenatoRx Pharmaceuticals Receives $9.4 Million Award from CARB-X to Develop a New Class of Antibiotic to Combat Multi-Dr...
